Management of upper limb dysfunction in children with cerebral palsy: a systematic review

被引:173
作者
Boyd, RN
Morris, ME
Graham, HK
机构
[1] Royal Childrens Hosp, Hugh Williamson Gait Lab, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia
[2] La Trobe Univ, Sch Physiotherapy, Bundoora, Vic 3083, Australia
关键词
botulinum toxin type A; cerebral palsy; constraint induced movement therapy; movement disorders; physical therapy; systematic review; upper limb;
D O I
10.1046/j.1468-1331.2001.00048.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Effective use of the upper limb can impact on educational outcomes. participation in activities of daily living and vocational options for many children with cerebral palsy (CP). This article presents the results of a systematic review of the literature on the management of upper limb dysfunction in children with CP. The range of management options includes therapies such as physiotherapy, occupational therapy, neurodevelopmental therapy and conductive education, peripheral splinting and casting, focal or generalized pharmacotherapy; and surgery to improve upper limb function or correct deformity. A literature search identified 60 papers. of which four were randomized controlled trials and 44 were prospective studies with objective Outcome measures. Principal studies undertaken for each type of treatment and the efficacy of the different types of treatment were critically evaluated. In addition. the current level of evidence for each study was evaluated according to Sackett's (1989) model and ICIDH-2 classification. A close examination of two relatively new treatments for upper limb spasticity, constraint induced movement therapy and botulinum toxin type A (BTX-A) was conducted with reference to more extensive data on the efficacy of BTX-A in the lower limb.
引用
收藏
页码:150 / 166
页数:17
相关论文
共 103 条
[1]  
ADA L, 1990, KEY ISSUES NEUROLOGI
[2]  
ALBRIGHT AL, 1995, PEDIATR NEUROSURG, V23, P82
[3]   CONTINUOUS INTRATHECAL BACLOFEN INFUSION FOR SPASTICITY OF CEREBRAL ORIGIN [J].
ALBRIGHT, AL ;
BARRON, WB ;
FASICK, MP ;
POLINKO, P ;
JANOSKY, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (20) :2475-2477
[4]   Multidimensional assessment of motor function in a child with cerebral palsy following intrathecal administration of baclofen [J].
Almeida, GL ;
Campbell, SK ;
Girolami, GL ;
Penn, RD ;
Corcos, DM .
PHYSICAL THERAPY, 1997, 77 (07) :751-764
[5]  
[Anonymous], PEDro Physiotherapy Evidence Database
[6]  
[Anonymous], CLIN DEV MED
[7]   Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin [J].
Armstrong, RW ;
Steinbok, P ;
Cochrane, DD ;
Kube, SD ;
Fife, SE ;
Farrell, K .
JOURNAL OF NEUROSURGERY, 1997, 87 (03) :409-414
[8]   Management of the upper limb with botulinum toxin type A in children with spastic type cerebral palsy and acquired brain injury:: clinical implications [J].
Autti-Rämö, I ;
Larsen, A ;
Taimo, A ;
von Wendt, L .
EUROPEAN JOURNAL OF NEUROLOGY, 2001, 8 :136-144
[9]   Botulinum toxin injection as an adjunct when planning hand surgery in children with spastic hemiplegia [J].
Autti-Rämö, I ;
Larsen, A ;
Peltonen, J ;
Taimo, A ;
von Wendt, L .
NEUROPEDIATRICS, 2000, 31 (01) :4-8
[10]   IMPROVEMENT IN UPPER EXTREMITY FUNCTION AND TRUNK CONTROL AFTER SELECTIVE POSTERIOR RHIZOTOMY [J].
BECK, AJ ;
GASKILL, SJ ;
MARLIN, AE .
AMERICAN JOURNAL OF OCCUPATIONAL THERAPY, 1993, 47 (08) :704-707